biOasis Technologies Ord Shs V.BTI.H

Grow up and move on please...

[OysterBuctouche]

Read the financials. Either a deal is imminent or this company gets sold. Real soon on either option. Stop your nonsense please.

[JDavenport]

That's funny, OB Wan. You broke the spell. Nobody posted anything for three days until you posted your own improved, very special and higher class nonsense. But sanctimoney is therapeutic for the finger wagger. We get that part. jd

[KayakerBC]

Read the financials. Either a deal is imminent or this company gets sold. Real soon on either option. Stop your nonsense please. As I've posted before, if the company will be sold I would prefer an outright sell if possible -- $2 US per share would be fine, I'll hold my nose and vote yes for $1 US. I'd be opposed to a Contingency Value Rights (CVR) deal.  Some small amount of

[JDavenport]

I'm with KayakerBC, totally, on the CVR question. It's a strategy that completely favours the acquiring company.   If you look up how the acquiring companies value their sides of CVRs, you will find all sorts of either liability or equity valuations that are heavily discounted and otherwise finagled to present to their own shareholders how little they'll owe in the future to

[JDavenport]

I was asked a question about my CVR comments, specifically about how the acquiring companies place a value on their CVR liability for reporting purposes. I was not suggesting that the acquiring companies "cook the books" to convince their shareholders that their CVR liabilities are smaller than the agreed upon terms of their agreements with the selling companies. Instead, it's a

[beenthere]

I am already  on record for my opinion of a CVR! Not sure about KBC but  I am sure about you JD! You either don't understand what you read or you  just want to play stupid ( well maybe it's not playing)! Or you are so in a rush to post you don't think first before you do! KBC and JD go back and read OB's post AND then come back here and SHOW ME where he mentioned

[JDavenport]

OB mentioned a buyout or deal, beenthere. KBC, quite naturally, put the CVR into the discussion. I commented because I had done a search on how the acquiring companies value the CVRs as liabilities in their financials.   It was a logical progression, beenthere, but logic not being your long suit, then... jd

[beenthere]

"quite naturally, put the CVR into the discussion" .....It was a logical progression .... No, not really!! Most deals are done ( nearly all ) without using CVR! Actually I wouldn't brought it up and put the idea into drdr's mind! She doesn't have enough smarts to think of it herself!

[KayakerBC]

Beenthere, I took a look at what you wrote after I saw JD's comment.  When I tried to take you off ignore, the popup box said "Are you sure?".  I wasn't, so didn't. 1. Oyster B commented that the company might be sold. 2. I responded with my opinion on two possibilities, one I would prefer (outright sell) and one I would not (CVR). 3. You responded with "

[JDavenport]

The CVR topic was addressed because of the rumour posted by lovingold where he stated, "anyone else hearing... ...a buyout by a certain pharma in the range of $35m USD plus some contingency rights?" All discussion about CVRs was driven by that post. beenthere, you have to stop. You're falling way behind the discussion. Actually reading posts instead of just shooting your mouth off

[Comonreally42]

So far, I have been right more than most ( esp JD). I say no one will buy this, and there isnt deal about to happen to make this BBB journey come true. I say they fold and delist but not before it gets milked some more by those in charge currently or an executive change one more time before folding. Any takers? And JD, business tip, dont write a book on this topic, it will be as successfull as

[JDavenport]

I won't be writing the story of Bioasis, Comonreally42, but the situation and the people can form part of a larger fiction. You know what they say. Write what you know. Therefore, we have no reason to expect writings from you. So, if Bioasis cannot be sold, and if it cannot attract deals, then would you describe to us what the problem with xB3 is, please? jd

[Comonreally42]

xB3 ( stupid name) has little to no commercial value. After 14 years the stock sits .145 cents and not one Pharma has steped up in a material way. The runway is short, its a heavy plane with a payload that is questionable and all the pilots in the world likely couldnt of got this off the ground. Maybe start pulling stats on penny stocks that just delist, close their doors and drift off into the

[JDavenport]

Comonreally42 says that xB3 "...has little to no commercial value." So that means he can't answer the question, "What's wrong with xB3?" Speaking of clinging on, Comonreally42, your obsession with me is much harder to explain than my interest in Bioasis. I'm your only reason for being here. So the very apt "cling-on" metaphor will likely stick with you